Literature DB >> 21123488

Treatment gap for people living with epilepsy in Madagascar.

Voa Ratsimbazafy1, Rakotobe Andrianabelina, Sonia Randrianarisona, Pierre-Marie Preux, Peter Odermatt.   

Abstract

Using an indirect assessment technique we assessed the epilepsy treatment gap (ETG) in Madagascar. We estimate the ETG in Madagascar to be 92%. However, given the sociological, economic and sanitary conditions of the country, it is likely that the true ETG is even higher than our estimate. Our study also documents the lack of access to treatment for patients in this developing country. The indirect method could be used to assess the treatment gaps of other chronic medical conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123488     DOI: 10.1258/td.2010.100254

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Epilepsy is different.

Authors:  Rhys H Thomas; Phil E M Smith
Journal:  J R Soc Med       Date:  2011-04       Impact factor: 5.344

Review 2.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.

Authors:  Awa Ba-Diop; Benoît Marin; Michel Druet-Cabanac; Edgard B Ngoungou; Charles R Newton; Pierre-Marie Preux
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

3.  Availability and cost of major and first-line antiepileptic drugs: a comprehensive evaluation in the capital of Madagascar.

Authors:  Jeremy Jost; Adeline Raharivelo; Voa Ratsimbazafy; Mandy Nizard; Emilie Auditeau; Charles R Newton; Pierre-Marie Preux
Journal:  Springerplus       Date:  2016-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.